Product Overview
The Retatrutide Triple Agonist Pen by AMPLEXA CARE is a highly specialized, pre-filled delivery system designed exclusively for advanced laboratory research and in vitro studies. This innovative product provides researchers with a precise, 40mg formulation of Retatrutide, a novel compound engineered to simultaneously activate three distinct metabolic pathways: Glucagon-Like Peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and Glucagon receptors.
By targeting these three critical receptors, this triple agonist offers a comprehensive tool for investigating complex metabolic processes, endocrine signaling, and cellular responses. The pen format ensures accurate, consistent dosing for once-weekly experimental protocols, minimizing handling errors and maintaining the integrity of the compound throughout your study.
Key Specifications
|
Specification
|
Detail
|
|
Active Compound
|
Retatrutide (Triple Agonist)
|
|
Receptor Targets
|
GLP-1, GIP, and Glucagon Receptors
|
|
Concentration/Dose
|
40mg per pre-filled pen
|
|
Delivery Method
|
Pre-filled, multi-dose injection pen
|
|
Intended Protocol
|
Designed for once-weekly administration in research models
|
|
Storage Requirements
|
Must be stored in a refrigerator (2°C to 8°C)
|
|
Intended Use
|
For Research Purposes Only. Not for human or animal consumption.
|
Research Applications
The Retatrutide Triple Agonist Pen is an invaluable asset for laboratories focused on metabolic and endocrine research. Its unique tri-agonist mechanism allows scientists to study the synergistic effects of simultaneous receptor activation. This product is particularly suited for:
•Investigating the pathways involved in glucose homeostasis and lipid metabolism.
•Studying cellular signaling cascades triggered by multi-receptor engagement.
•Developing comparative models against single or dual-agonist compounds.
•Advancing structural biology and protein interaction studies related to metabolic regulation.
Quality and Compliance
AMPLEXA CARE is committed to providing the scientific community with materials of the highest purity and reliability. The Retatrutide Triple Agonist Pen is manufactured under strict quality control standards to ensure consistency across batches.
Important Safety and Handling Information: This product is strictly designated for laboratory research and development purposes only. It is not intended for diagnostic, therapeutic, or clinical use in humans or animals. Researchers must handle this compound in accordance with standard laboratory safety protocols and institutional guidelines. Please consult the included package leaflet for comprehensive handling, storage, and safety instructions prior to use.
Reviews
There are no reviews yet.